BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- Product NDC
- 61919-022
- 11-digit product format
- 619190022
- Labeler code
- 61919
- Product ID
- 61919-022_a6b845c8-1065-4f9e-e053-2995a90aa6bc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA089175
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Marketing end
- 0000-00-00
- Substance
- BUTALBITAL; ACETAMINOPHEN; CAFFEINE
- Active strength
- 50 mg/1; mg/1; mg/1
- Pharmacologic classes
- Barbiturates [CS],Barbiturate [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 61919-022-30 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-60 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-90 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-30 | 2020-06-02 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-60 | 2020-06-02 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-90 | 2020-06-02 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| 61919-022-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4e64-f424-e053-dadaa90a57ce | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-022-30 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | 30 in 1 BOTTLE | TABLET | 30 | | 8 |
| 61919-022-60 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | 60 in 1 BOTTLE | TABLET | 60 | | 8 |
| 61919-022-90 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | 90 in 1 BOTTLE | TABLET | 90 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| BUTALBITAL | ACTIVE INGREDIENT | KHS0AZ4JVK | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| BUTALBITAL | ACTIVE MOIETY | KHS0AZ4JVK | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-022 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET [DIRECT RX] | 8 | Legacy NDC, 3 package rows | 20230331_c0a97823-63d5-43fa-862f-2acce3185681.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-022-30 | 61919002230 | 30 TABLET in 1 BOTTLE (61919-022-30) | 30 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-022-60 | 61919002260 | 60 TABLET in 1 BOTTLE (61919-022-60) | 60 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-022-90 | 61919002290 | 90 TABLET in 1 BOTTLE (61919-022-90) | 90 tablet | 2014-01-01 | 0000-00-00 | No | No | Current |